About
Titles
Associate Professor of Medicine (Cardiovascular Medicine)
Chief, Heart Failure Program
Biography
I am the Chief of Heart Failure at Yale Cardiology. I focus on the care of patients with end stage heart failure, left ventricular assist devices, and heart transplants. My Internal Medicine training was at Brigham and Women's Hospital, Harvard Medical School in Boston. During that time, I received an MPH from Harvard School of Public Health. I did my fellowship in Cardiovascular Medicine and Advanced Heart Failure at Duke University Medical Center along with a two year research fellowship at DCRI. My research interest is in using data to improve the care of heart failure patients. I partner with several investigators at Yale to run pragmatic clinical trials across the health system that are aimed at answering foundational questions about the practice of heart failure.
Appointments
Cardiovascular Medicine
Associate Professor on TermPrimary
Other Departments & Organizations
- Cardiovascular Medicine
- Clinical and Translational Research Accelerator (CTRA)
- Heart Failure Program
- Heart Transplant and Left Ventricular Assist Device Program
- Internal Medicine
- Yale Medicine
- Yale New Haven Health System
Education & Training
- Advanced Heart Failure Fellow
- Duke University Medical Center (2015)
- Fellow
- Duke University Medical Center (2014)
- Research Fellow
- Duke Clinical Research Institute (2014)
- MPH
- Harvard School of Public Health (2010)
- Intern and Resident
- Brigham and Women's Hospital (2010)
- MD
- SUNY at Stony Brook School of Medicine (2006)
- BA
- New York University, Mathematics and Biology (2001)
Research
Publications
2026
Are We Setting Heart Failure Drug Development Up for Failure?
Sen S, Ahmad T. Are We Setting Heart Failure Drug Development Up for Failure? JACC Heart Failure 2026, 103282. PMID: 42554538, DOI: 10.1016/j.jchf.2026.103282.Commentaries, Editorials and LettersTarget Versus Below-Target Dose ACE Inhibitors in U.S. Veterans with HFpEF: Differential Outcomes by CKD Status
Lu F, Ahmed A, Zhang S, Raman V, Patel S, Vargas J, Fonarow G, Heidenreich P, Cleland J, Anker S, Böhm M, Metra M, Zile M, Bhatt D, Ahmad T, Lam P, Moore H, Faselis C, Morgan C, Sheriff H, Zeng-Treitler Q, Wu W, Ahmed A. Target Versus Below-Target Dose ACE Inhibitors in U.S. Veterans with HFpEF: Differential Outcomes by CKD Status. European Journal Of Heart Failure 2026, xuag237. PMID: 42530463, DOI: 10.1093/ejhf/xuag237.Peer-Reviewed Original ResearchPromoting palliative care for people with heart failure: the P3HF study protocol
Men Y, Wright N, O’Connor G, Han L, Kaur H, Suh E, Chen J, Kadhim B, Ahmad T, Beasley M, Segar N, Kim N, Quang J, Sharifi M, Feder S. Promoting palliative care for people with heart failure: the P3HF study protocol. BMC Palliative Care 2026 PMID: 42432643, DOI: 10.1186/s12904-026-02206-w.Peer-Reviewed Original ResearchScaling a Lipid-Lowering Clinical Decision Support Intervention Across the U.S. Health Systems: Lessons Learned from the PROMPT-LIPID Multicenter Study
Kadhim B, Yasmin F, Riello R, Pandit A, Davidson D, Davis E, Salome G, Englert J, Jones L, Martin M, Pohlman F, Ferris C, Maddox T, Desai N, Subramanian S, Yamamoto Y, Ahmad T, Wilson F. Scaling a Lipid-Lowering Clinical Decision Support Intervention Across the U.S. Health Systems: Lessons Learned from the PROMPT-LIPID Multicenter Study. American Journal Of Preventive Cardiology 2026, 101765. DOI: 10.1016/j.ajpc.2026.101765.Peer-Reviewed Original ResearchDesigning a clinical decision support tool to promote timely palliative care in heart failure
Men Y, Wright N, O'Connor G, Kaur H, Suh E, Chen J, Kadhim B, Ahmad T, Beasley M, Segar N, Quang J, Sharifi M, Feder S. Designing a clinical decision support tool to promote timely palliative care in heart failure. Heart & Lung 2026, 79: 102821. PMID: 42068688, PMCID: PMC13206645, DOI: 10.1016/j.hrtlng.2026.102821.Peer-Reviewed Original ResearchTarget-dose vs below-target-dose ACE inhibitors and lower risk of kidney failure and mortality in US Veterans with HFrEF
Ahmed A, Lu F, Zhang S, Raman V, Patel S, Morgan C, Faselis C, Lam P, Fonarow G, Heidenreich P, Ahmad T, Anker S, Metra M, Pitt B, Butler J, Zullo A, Moore H, Vargas J, Arundel C, Sánchez-Vallejo C, Deedwania P, Sheriff H, Zeng-Treitler Q, Wu W, Ahmed A. Target-dose vs below-target-dose ACE inhibitors and lower risk of kidney failure and mortality in US Veterans with HFrEF. European Journal Of Heart Failure 2026, xuag076. PMID: 41797492, DOI: 10.1093/ejhf/xuag076.Peer-Reviewed Original Research
2025
Framework for Analytical Validation of DHT-Based Actigraphy and Signal Measures in HF Trials The VALIDATE-HF Program
Kose O, Sahal A, Zhang G, Possik E, Fiuzat M, Psotka M, Kao D, Shalowitz E, Martyn T, Kittipibul V, Ni W, Tingley W, Vlajnic V, Abildstrøm S, Cowie M, Majmudar M, Ahmad T, Leifer E, Fudim M, O'Connor C, Sharma A. Framework for Analytical Validation of DHT-Based Actigraphy and Signal Measures in HF Trials The VALIDATE-HF Program. JACC Heart Failure 2025, 14: 102831. PMID: 41369636, DOI: 10.1016/j.jchf.2025.102831.Commentaries, Editorials and LettersManagement of Ischemic Heart Disease in Patients With Heart Failure JACC: Heart Failure Position Statement
Mielniczuk L, Ahmad T, Borovac J, Brown K, Cooper L, Fida N, Hochman J, Al Lamee R, Lawton J, Narang N, Perera D, Petrie M, Rajagopalan N, Reza N, Stone P, Tamis-Holland J, Velazquez E. Management of Ischemic Heart Disease in Patients With Heart Failure JACC: Heart Failure Position Statement. JACC Heart Failure 2025, 13: 102731. PMID: 41338831, PMCID: PMC13038397, DOI: 10.1016/j.jchf.2025.102731.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsThe challenges of using electronic medical records (EMR) to facilitate guideline-directed medical therapy (GDMT) for patients with heart failure (HF) and chronic kidney disease (CKD)
Desai N, Ahmad T, Wilson F. The challenges of using electronic medical records (EMR) to facilitate guideline-directed medical therapy (GDMT) for patients with heart failure (HF) and chronic kidney disease (CKD). Heart Failure Reviews 2025, 30: 1489-1497. PMID: 41073617, PMCID: PMC12618310, DOI: 10.1007/s10741-025-10564-5.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsRelationship between industry payments to physicians and prescription patterns for PCSK9is, ARNis and DOACs: A report from the NCDR PINNACLE registry
Annapureddy A, Murugiah K, Zheng L, Minges K, Grandhi G, Ross J, Ahmad T, Rodwin B, Dhruva S, Girotra S, Dayoub E, Curtis J, Desai N. Relationship between industry payments to physicians and prescription patterns for PCSK9is, ARNis and DOACs: A report from the NCDR PINNACLE registry. American Heart Journal 2025, 291: 26-36. PMID: 40714034, PMCID: PMC12621269, DOI: 10.1016/j.ahj.2025.07.015.Peer-Reviewed Original Research
Academic Achievements & Community Involvement
Clinical Care
Overview
Tariq Ahmad, MD, MPH, is a cardiologist who specializes in treating patients with end-stage heart failure and heart transplants. He also cares for patients with cardiomyopathies, which are diseases of the heart muscle, and advanced valvular diseases. “I help take care of patients who have been told that they are out of options. In some ways, it’s like the oncology of cardiology,” Dr. Ahmad says.
Dr. Ahmad traces his love of medicine to his grandfather, a surgeon, who would allow him to follow along on hospital rounds. But his decision to pursue cardiology happened with more serendipity. “In medical school, I read a cardiology textbook that was just beautifully written. It was an outstanding book and I kept reading it and decided I would pursue that specialty,” Dr. Ahmad says.
“For hundreds of years we’ve developed a physical exam around the properties of the heart,” he says. “There’s lots of dimensions to it that are absolutely fascinating.”
Away from his patients’ bedsides, Dr. Ahmad is deeply involved in research that attempts to better understand how heart failure happens. “I’ve investigated blood molecules that can help predict who is going to have more advanced diseases, and who is not. These are called biomarkers, and we are still working to improve them.”
At Yale School of Medicine, Dr. Ahmad is an assistant professor of cardiology.
Clinical Specialties
Fact Sheets
Ventricular Assist Device (VAD)
Learn More on Yale MedicineExtracorporeal Membrane Oxygenation (ECMO)
Learn More on Yale MedicineHeart Transplant
Learn More on Yale MedicineHeart Disease in Women
Learn More on Yale Medicine
Yale Medicine News
News & Links
Media
News
- December 01, 2025
The GLP-1 Revolution
- April 01, 2024
Yale Faculty Present Groundbreaking Clinical Research at the 2024 American College of Cardiology Scientific Sessions
- June 06, 2023Source: Medscape
EHR Nudges a Bust for Boosting Guideline-Directed Meds in Acute HF: PROMPT-AHF
- June 01, 2023Source: TCTMD
Boosting GDMT and Improving Outcomes? No Mean Task After AHF
Get In Touch
Contacts
Locations
Patient Care Locations
Are You a Patient? View this doctor's clinical profile on the Yale Medicine website for information about the services we offer and making an appointment.